tiprankstipranks
Karuna Therapeutics (KRTX)
NASDAQ:KRTX
US Market
Holding KRTX?
Track your performance easily

Karuna Therapeutics (KRTX) Stock News & Sentiment

457 Followers
Karuna Therapeutics Undergoes Extensive Corporate Transformation
Premium
Company Announcements
Karuna Therapeutics Undergoes Extensive Corporate Transformation
8M ago
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
Premium
Market News
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
11M ago
M & A News: Bristol-Myers (NYSE:BMY) to Acquire Karuna for $14B
Premium
Market News
M & A News: Bristol-Myers (NYSE:BMY) to Acquire Karuna for $14B
11M ago

News Score - Last 7 Days

Neutral
KRTX
Sector Average
Media Buzz
This Week3 articles
Weekly Average4 articles
News Sentiment
This Week100%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KRTX’s Media Buzz Sentiment?
3 articles about KRTX were published this week. In an average week, 4 articles are published.
    What is KRTX’s weekly average amount of articles?
    In an average week, 4 articles about KRTX are published.
      What is KRTX’s News Sentiment?
      100% of articles about KRTX were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        SERASera Prognostics
        FUSNFusion Pharmaceuticals
        TNYATenaya Therapeutics
        HITIHigh Tide
        LIFEaTyr Pharma
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis